Cargando…
Cost-effectiveness and value-based prices of the 9-valent human papillomavirus vaccine for the prevention of cervical cancer in China: an economic modelling analysis
OBJECTIVES: To evaluate the cost-effectiveness of the 9-valent human papillomavirus (HPV) vaccine for the prevention of cervical cancer in China. DESIGN: Health economic modelling using the Papillomavirus Rapid Interface for Modelling and Economics (PRIME) model populated with China-specific data. S...
Autores principales: | Jiang, Y, Ni, Weiyi, Wu, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6886925/ https://www.ncbi.nlm.nih.gov/pubmed/31767588 http://dx.doi.org/10.1136/bmjopen-2019-031186 |
Ejemplares similares
-
Cost-effectiveness of human papillomavirus vaccine in China: a systematic review of modelling studies
por: Shi, Wenchuan, et al.
Publicado: (2021) -
Price elasticity of tobacco products among economic classes in India, 2011–2012
por: Selvaraj, Sakthivel, et al.
Publicado: (2015) -
Estimation of cost-based prices for injectable medicines in the WHO Essential Medicines List
por: Gotham, Dzintars, et al.
Publicado: (2019) -
Real price of health-experiences of out-of-pocket costs in Australia: protocol for a systematic review
por: Wang, Shelley Ting-Li, et al.
Publicado: (2022) -
Lifetime quality of life and cost consequences of delays in endovascular treatment for acute ischaemic stroke: a cost-effectiveness analysis from a Singapore healthcare perspective
por: Ni, Weiyi, et al.
Publicado: (2020)